Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Laboratory Corp. of America Holdings    LH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Laboratory Corp. of America Holdings : LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/13/2012 | 10:05pm CEST

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that for the period of March 12, 2012 to September 11, 2012, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended March 7, 2012, in addition to the continued accrual of the original issue discount. Contingent cash interest, which the Company has determined to be approximately $1.50 per Note, will be payable to holders of the Zero Coupon Notes as of the record date, which is August 26, 2012. The payment of contingent cash interest is expected to be made on September 11, 2012.

About LabCorp®

Laboratory Corporation of America® Holdings, an S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $5.5 billion in 2011, over 31,000 employees worldwide, and more than 220,000 clients, LabCorp offers more than 4,000 tests ranging from routine blood analyses to reproductive genetics to companion diagnostics. LabCorp furthers its scientific expertise and innovative clinical testing technology through its specialized labs and the LabCorp Specialty Testing Group: The Center for Molecular Biology and Pathology, National Genetics Institute, ViroMed Laboratories, Inc., The Center for Esoteric Testing, Litholink Corporation, Integrated Genetics, Integrated Oncology, DIANON Systems, Inc., Monogram Biosciences, Inc., Colorado Coagulation, and Endocrine Sciences. LabCorp conducts clinical trials testing through its Esoterix Clinical Trials Services. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our organization, visit our Web site at: www.labcorp.com.

This press release contains forward-looking statements. Each of the forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Actual results could differ materially from those suggested by these forward-looking statements. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10-K for the year ended December 31, 2011, and subsequent SEC filings.

LabCorp
Stephen Anderson, 336-436-5274
www.labcorp.com


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LABORATORY CORP. OF AMERIC
05/23 LABORATORY OF AMERICA : LabCorp Exclusively Launches Sera Prognostics’ Pre..
05/23 THE BUSINESS RESEARCH COMPANY : Asia accounted for $1.4 trillion in the healthca..
05/19 LABORATORY OF AMERICA : LabCorp completes acquisition of PAML
05/17 LABORATORY CORPORATION OF AMERICA HO : LH) Files An 8-K Submission of Matters to..
05/17 LABORATORY CORP OF AMERICA HOLDINGS : Submission of Matters to a Vote of Securit..
05/11 INSIDER TRADING ACTIVITY LABORATORY : LH) – Director Sold 992 shares of S..
05/09 LABORATORY OF AMERICA : LabCorp is Scheduled to Present at the Bank of America M..
05/09 LABORATORY OF AMERICA : Research Reports Initiation on Medical Labs Stocks -- Or..
05/05 LABORATORY OF AMERICA : LabCorp completes purchase of Spokane's PAML
05/04 LABORATORY OF AMERICA : LabCorp Completes Acquisition of Pathology Associates Me..
More news
Sector news : Healthcare Facilities & Services - NEC
05/24 FTSE edges up helped by M&S, but miners weigh
05/24 Middle East rules hurts South Africa's Mediclinic earnings
05/19DJIHH HEALTHCARE BHD : Malaysia's IHH Healthcare 1Q Net Profit Rises
05/03DJFRESENIUS : Sales, Profit Increased in 1st Quarter -- Update
05/03DJFRESENIUS : Sales, Profit Increased in 1st Quarter
More sector news : Healthcare Facilities & Services - NEC
News from SeekingAlpha
04:12a Tracking Larry Robbins's Glenview Capital Management Portfolio - Q1 2017 Upda..
05/24 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q1 2017 Upda..
05/23 LabCorp launches blood test for preterm birth risk
04/25 LabCorp extends process improvement initiative to Covance, $30M charge planne..
04/25 LabCorp Q1 sales up 5%; eaarnings up 17%; non-GAAP EPS up 8%; updates 2017 gu..
Advertisement
Financials ($)
Sales 2017 9 868 M
EBIT 2017 1 608 M
Net income 2017 855 M
Debt 2017 5 073 M
Yield 2017 -
P/E ratio 2017 17,04
P/E ratio 2018 15,77
EV / Sales 2017 1,97x
EV / Sales 2018 1,82x
Capitalization 14 410 M
More Financials
Chart LABORATORY CORP. OF AMERIC
Duration : Period :
Laboratory Corp. of Americ Technical Analysis Chart | LH | US50540R4092 | 4-Traders
Full-screen chart
Technical analysis trends LABORATORY CORP. ...
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 156 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David P. King Chairman, President & Chief Executive Officer
Glenn A. Eisenberg Chief Financial Officer, Treasurer & Executive VP
Mark Elliott Brecher Chief Medical Officer & Senior Vice President
Lance V. Berberian Chief Information Officer & Senior Vice President
Marcia T. Eisenberg Chief Scientific Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LABORATORY CORP. OF AM..8.82%14 371
HCA HEALTHCARE INC11.36%30 204
FRESENIUS MEDICAL CARE..1.40%28 331
QUEST DIAGNOSTICS INC15.90%14 579
DAVITA INC0.89%12 590
UNIVERSAL HEALTH SERVI..9.10%11 591
More Results